See more : BB Biotech AG (BION.SW) Income Statement Analysis – Financial Results
Complete financial analysis of Guangzhou Jointas Chemical Co., Ltd. (002909.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Guangzhou Jointas Chemical Co., Ltd., a leading company in the Chemicals – Specialty industry within the Basic Materials sector.
- PHI Group Inc. (PHIGW) Income Statement Analysis – Financial Results
- DT Capital Limited (0356.HK) Income Statement Analysis – Financial Results
- Drägerwerk AG & Co. KGaA (DGWPF) Income Statement Analysis – Financial Results
- Lealea Enterprise Co., Ltd. (1444.TW) Income Statement Analysis – Financial Results
- M.Yochananof and Sons (1988) Ltd (YHNF.TA) Income Statement Analysis – Financial Results
Guangzhou Jointas Chemical Co., Ltd. (002909.SZ)
About Guangzhou Jointas Chemical Co., Ltd.
Guangzhou Jointas Chemical Co., Ltd. research, development, production, and sale of sealants and coatings in China. The company offers door and window, hollow, assembly, photovoltaic, and transformer glue products, as well as glue for electronic equipment and indoor use; curtain wall, petrochemical, steel structure, machinery and equipment, automotive marine, and rail transport adhesive products, as well as adhesive for LED lighting; interior and exterior paint; and silicone oil products. It sells its products under the Antai and Jitai brands. The company was founded in 1989 and is based in Guangzhou, China.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1.33B | 1.45B | 1.68B | 1.26B | 1.02B | 932.62M | 802.17M | 501.37M | 506.01M | 536.26M | 453.31M | 408.09M |
Cost of Revenue | 999.44M | 1.14B | 1.32B | 865.86M | 658.44M | 703.04M | 567.98M | 308.25M | 316.28M | 361.91M | 315.08M | 293.79M |
Gross Profit | 332.96M | 311.68M | 352.52M | 392.85M | 357.61M | 229.58M | 234.19M | 193.12M | 189.74M | 174.35M | 138.23M | 114.30M |
Gross Profit Ratio | 24.99% | 21.49% | 21.04% | 31.21% | 35.20% | 24.62% | 29.19% | 38.52% | 37.50% | 32.51% | 30.49% | 28.01% |
Research & Development | 65.63M | 60.98M | 69.22M | 52.95M | 37.76M | 34.74M | 27.35M | 8.89M | 12.51M | 16.63M | 18.97M | 15.03M |
General & Administrative | 28.13M | 23.81M | 24.14M | 21.87M | 21.88M | 15.05M | 16.15M | 13.80M | 14.27M | 10.72M | 42.88M | 37.75M |
Selling & Marketing | 76.11M | 124.67M | 129.47M | 112.10M | 142.04M | 125.29M | 104.10M | 78.11M | 68.72M | 55.70M | 40.29M | 27.99M |
SG&A | 227.60M | 148.48M | 153.61M | 133.97M | 163.93M | 140.35M | 120.25M | 91.91M | 83.00M | 66.42M | 83.18M | 65.74M |
Other Expenses | 26.60M | 51.73M | 49.11M | 43.95M | 38.71M | -1.08M | 218.48K | 2.07M | 2.18M | 771.57K | 371.16K | 653.05K |
Operating Expenses | 319.84M | 261.19M | 271.94M | 230.87M | 240.40M | 198.87M | 172.07M | 133.09M | 124.07M | 108.80M | 85.25M | 67.86M |
Cost & Expenses | 1.32B | 1.40B | 1.59B | 1.10B | 898.84M | 901.91M | 740.06M | 441.34M | 440.35M | 470.71M | 400.33M | 361.65M |
Interest Income | 716.26K | 2.34M | 4.78M | 2.98M | 2.32M | 1.66M | 1.17M | 1.13M | 1.48M | 1.36M | 0.00 | 3.56M |
Interest Expense | 30.02M | 24.82M | 16.47M | 13.31M | 6.95M | 5.39M | 4.94M | 6.03M | 7.44M | 6.29M | 4.25M | 0.00 |
Depreciation & Amortization | 59.44M | 52.71M | 42.15M | 29.86M | 26.36M | 18.51M | 13.98M | 5.63M | 9.86M | 8.21M | 13.93M | 8.91M |
EBITDA | 99.76M | 85.06M | 109.05M | 180.36M | 132.64M | 50.12M | 72.65M | 64.40M | 73.74M | 49.04M | 57.64M | 48.84M |
EBITDA Ratio | 7.49% | 6.88% | 7.40% | 15.03% | 13.83% | 5.10% | 9.35% | 14.81% | 15.55% | 14.11% | 12.72% | 11.97% |
Operating Income | 13.12M | 51.13M | 85.18M | 137.29M | 103.63M | 27.04M | 53.39M | 51.27M | 59.05M | 38.82M | 43.71M | 39.93M |
Operating Income Ratio | 0.99% | 3.53% | 5.08% | 10.91% | 10.20% | 2.90% | 6.66% | 10.23% | 11.67% | 7.24% | 9.64% | 9.78% |
Total Other Income/Expenses | -1.97M | -39.52M | -31.36M | -881.09K | -1.05M | -1.08M | 218.48K | 1.39M | 1.84M | 472.38K | 187.45K | -3.47M |
Income Before Tax | 11.15M | 11.61M | 53.82M | 136.41M | 102.58M | 25.96M | 53.61M | 52.66M | 60.89M | 39.30M | 43.90M | 40.58M |
Income Before Tax Ratio | 0.84% | 0.80% | 3.21% | 10.84% | 10.10% | 2.78% | 6.68% | 10.50% | 12.03% | 7.33% | 9.68% | 9.94% |
Income Tax Expense | 904.13K | 1.44M | 3.12M | 23.65M | 16.89M | 7.21M | 8.36M | 9.97M | 11.93M | 11.67M | 7.82M | 7.37M |
Net Income | 10.24M | 10.19M | 50.69M | 111.75M | 85.42M | 18.74M | 45.24M | 42.69M | 48.95M | 27.62M | 36.09M | 33.21M |
Net Income Ratio | 0.77% | 0.70% | 3.03% | 8.88% | 8.41% | 2.01% | 5.64% | 8.52% | 9.67% | 5.15% | 7.96% | 8.14% |
EPS | 0.03 | 0.03 | 0.14 | 0.34 | 0.26 | 0.06 | 0.17 | 0.17 | 0.20 | 0.14 | 0.15 | 0.13 |
EPS Diluted | 0.03 | 0.03 | 0.14 | 0.34 | 0.26 | 0.06 | 0.17 | 0.17 | 0.20 | 0.14 | 0.15 | 0.13 |
Weighted Avg Shares Out | 372.75M | 372.75M | 372.71M | 326.76M | 329.28M | 327.16M | 260.77M | 249.23M | 248.75M | 248.76M | 248.76M | 248.76M |
Weighted Avg Shares Out (Dil) | 372.75M | 372.75M | 372.71M | 326.76M | 329.28M | 333.95M | 260.81M | 249.26M | 248.76M | 248.76M | 248.76M | 248.76M |
Source: https://incomestatements.info
Category: Stock Reports